Compare ACRS & CMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACRS | CMCL |
|---|---|---|
| Founded | 2012 | 1992 |
| Country | United States | Jersey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.9M | 452.1M |
| IPO Year | 2015 | 2003 |
| Metric | ACRS | CMCL |
|---|---|---|
| Price | $3.33 | $23.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $10.18 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 3.5M | 198.4K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 2.36% |
| EPS Growth | ★ 69.01 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,683,000.00 | N/A |
| Revenue This Year | N/A | $24.19 |
| Revenue Next Year | N/A | $6.55 |
| P/E Ratio | ★ N/A | $10.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.93 | $15.85 |
| 52 Week High | $6.60 | $36.35 |
| Indicator | ACRS | CMCL |
|---|---|---|
| Relative Strength Index (RSI) | 28.14 | 45.84 |
| Support Level | $3.16 | $22.24 |
| Resistance Level | $3.44 | $24.84 |
| Average True Range (ATR) | 0.33 | 0.88 |
| MACD | -0.08 | -0.08 |
| Stochastic Oscillator | 6.31 | 36.45 |
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. Its project includes Maligreen and Motapa.